Scarica l'app Stockscreener
33.75
0.15%
0.05
Dopo l'orario di chiusura:
33.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$33.70
Aprire:
$33.6
Volume 24 ore:
2.30M
Relative Volume:
0.58
Capitalizzazione di mercato:
$14.62B
Reddito:
$2.27B
Utile/perdita netta:
$1.15B
Rapporto P/E:
13.24
EPS:
2.55
Flusso di cassa netto:
$2.80B
1 W Prestazione:
+2.21%
1M Prestazione:
-0.15%
6M Prestazione:
+21.80%
1 anno Prestazione:
+11.50%
Intervallo 1D:
$33.60
$33.99
Intervallo di 1 settimana:
$33.00
$33.99
Portata 52W:
$24.05
$34.20
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
33.75 | 14.62B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
511.74 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
661.00 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
290.70 | 37.63B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ARGX
Argen X Se Adr
|
607.95 | 37.08B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ONC
Beigene Ltd Adr
|
253.20 | 27.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
15 Best Defensive Stocks Amid Market Volatility - Insider Monkey
Sciencast Management LP Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Royal London Asset Management Ltd. - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by HighTower Advisors LLC - MarketBeat
Fox Run Management L.L.C. Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Thrivent Financial for Lutherans Raises Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Technical Data - Stock Traders Daily
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Twin Tree Management LP - MarketBeat
Horizon Kinetics Asset Management LLC Purchases 90,380 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Swiss National Bank Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Koss Olinger Consulting LLC Invests $269,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - Barchart
Raymond James Financial Inc. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
How Do Investors Really Feel About Royalty Pharma? - Benzinga
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - Simply Wall St
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Tredje AP fonden - MarketBeat
Atria Investments Inc Sells 20,550 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jupiter Asset Management Ltd. Invests $4.95 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
AGF Management Ltd. Buys Shares of 98,512 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wealthfront Advisers LLC Buys 178,173 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Amundi Trims Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
River Road Asset Management LLC Trims Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Machina Capital S.A.S. Sells 12,740 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Proficio Capital Partners LLC Makes New $786,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Trims Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Victory Capital Management Inc. Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Menlo Advisors LLC - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stock Holdings Lifted by New South Capital Management Inc. - MarketBeat
Proficio Capital Partners LLC Invests $786,000 in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Metis Global Partners LLC Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Plato Investment Management Ltd - MarketBeat
Truist Financial Corp Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Cuts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Principal Financial Group Inc. Has $513,000 Holdings in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Torray Investment Partners LLC Has $17.45 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
SBI Securities Co. Ltd. Purchases New Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.68%
2.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):